Risks of HIV/AIDS treatment interruptions
- At: 2014 FIP Congress in Bangkok (Thailand)
- Type: Presentation
- By: GRAY, Andy (University of KwaZulu-Natal, Discipline of Pharmaceutical Services, Durban, South Africa)
Patients initiated on antiretroviral therapy are counselled that near-perfect adherence is required to avoid loss of viral suppression, the development of viral resistance, re-emergence of immune deficiency, and the resultant increased risk of incident opportunistic infections and neoplasms. However, a number of factors may contribute to unplanned.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.